Invention Grant
- Patent Title: Establishment and application of human immortalized B lymphocyte cell line group
-
Application No.: US16771921Application Date: 2018-11-09
-
Publication No.: US11643637B2Publication Date: 2023-05-09
- Inventor: Leming Shi , Yuanting Zheng , Wanwan Hou , Bin Li , Xingdong Chen , Ying Yu , Jiucun Wang , Li Jin
- Applicant: FUDAN UNIVERSITY
- Applicant Address: CN Shanghai
- Assignee: FUDAN UNIVERSITY
- Current Assignee: FUDAN UNIVERSITY
- Current Assignee Address: CN Shanghai
- Agency: Novick, Kim & Lee, PLLC
- Agent Allen Xue
- Priority: CN 1711309755.X 2017.12.11
- International Application: PCT/CN2018/114872 2018.11.09
- International Announcement: WO2019/114473A 2019.06.20
- Date entered country: 2020-06-11
- Main IPC: C12N5/0781
- IPC: C12N5/0781

Abstract:
The present application provides a group of human immortalized B lymphocyte cell lines and use thereof, and specifically provides a combination of four closely related immortalized lymphocyte cell lines. The combination can be used as a reference substances for measuring the performance of a detection platform. When the four closely related immortalized lymphocyte cell lines are used as reference substances for epigenome, transcriptome, proteome, and metabolome, an intrinsic magnitude difference gradient can be formed to evaluate the sensitivity of histological detection.
Public/Granted literature
- US20210087527A1 ESTABLISHMENT AND APPLICATION OF HUMAN IMMORTALIZED B LYMPHOCYTE CELL LINE GROUP Public/Granted day:2021-03-25
Information query